Delivery Order SPE2DB24D3013-SPE2DB24FFHXV

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The award has a ceiling value of $4,024.12 and an ultimate completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the government to efficiently procure a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medical devices. The award has a ceiling value of $1,187.60 and is a Firm Fixed Price contract with an ultimate completion date of October 29, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medication. The contract has a ceiling value of $1,878.64 and a period of performance through March 6, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, at a ceiling value of $1,891.12. The contract has a firm fixed price and a period of performance through November 2024. The delivery order does not have a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The $1,675.78 firm-fixed price contract has an ultimate completion date of August 23, 2024. This order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract (SPE2DX15D3015|SPE2DX24F0GR0) by the Defense Logistics Agency (DLA) Troop Support Medical to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The award has a ceiling value of $2,495.23 and a period of performance through March 25, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract has a ceiling value of $1,570.99 and is a firm fixed price agreement. The award date is August 5, 2024, and the ultimate completion date is August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,761.54 and a completion date of September 5, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, with a ceiling value of $1,068.84. The contract has an ultimate completion date of October 10, 2024 and was awarded on October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a ceiling value of $33,458.39 and a performance period through March 21, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFHXV
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract has a ceiling value of $1,627.57 and a period of performance through September 24, 2024. This order is placed under an Indefinite Delivery Contract (IDC) that DLA Troop Support Medical has with Amerisourcebergen, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation.

Generated 12/23/24, 2:22 PM